RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 76 filers reported holding RECRO PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,628 | -57.4% | 12,000 | 0.0% | 0.00% | – |
| Q2 2023 | $13,200 | -7.6% | 12,000 | 0.0% | 0.00% | – |
| Q1 2023 | $14,280 | -20.1% | 12,000 | 0.0% | 0.00% | – |
| Q4 2022 | $17,880 | -38.3% | 12,000 | -33.6% | 0.00% | – |
| Q3 2022 | $29,000 | +107.1% | 18,081 | +0.4% | 0.00% | – |
| Q2 2022 | $14,000 | -56.2% | 18,000 | 0.0% | 0.00% | – |
| Q1 2022 | $32,000 | +3.2% | 18,000 | 0.0% | 0.00% | – |
| Q4 2021 | $31,000 | -16.2% | 18,000 | 0.0% | 0.00% | – |
| Q3 2021 | $37,000 | -11.9% | 18,000 | 0.0% | 0.00% | – |
| Q2 2021 | $42,000 | -16.0% | 18,000 | 0.0% | 0.00% | – |
| Q1 2021 | $50,000 | -2.0% | 18,000 | 0.0% | 0.00% | – |
| Q4 2020 | $51,000 | +34.2% | 18,000 | 0.0% | 0.00% | – |
| Q3 2020 | $38,000 | -53.7% | 18,000 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $82,000 | -61.1% | 18,000 | 0.0% | 0.00% | -50.0% |
| Q1 2020 | $211,000 | -36.1% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $330,000 | – | 18,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |